This last observation is consistent with the findings of Shackelford et al. [34] who showed that loss of LKB1, a tumor suppressor that phosphorylates and activates AMPK, selectively enhances the anticancer effects of the biguanide phenformin. This evidence concerns the gene STK11 and neoplasm.